Q-omics provides the consensus-scored RNY1P2 profile across patient tissues and cancer cell-line models. RNY1P2 expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in HNSC. Additionally, RNY1P2 RNA expression shows 10,863 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight HNSC, and BRCA as cancer lineages where RNY1P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.